To confirm this, cycloheximide (CHX) chase assays were performed, revealing that A1BG knockdown significantly reduced the half‐life of NAMPT in osteosarcoma cells (Figure 5I; Figure S17, Supporting Information). This evidence concerns the gene NAMPT and osteosarcoma.